J Dewar

418 total citations
16 papers, 311 citations indexed

About

J Dewar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, J Dewar has authored 16 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Genetics. Recurrent topics in J Dewar's work include Global Cancer Incidence and Screening (4 papers), Bone health and treatments (3 papers) and Cancer Diagnosis and Treatment (3 papers). J Dewar is often cited by papers focused on Global Cancer Incidence and Screening (4 papers), Bone health and treatments (3 papers) and Cancer Diagnosis and Treatment (3 papers). J Dewar collaborates with scholars based in United Kingdom, France and Belgium. J Dewar's co-authors include G.R. Kerr, W. Duncan, C. Haie, A Gerbaulet, J Dutreix, Jean‐Marc Cosset, Thierry Le Chevalier, Gavin P. Lawrence, Olive Kearins and David Dodwell and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

J Dewar

16 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Dewar United Kingdom 10 164 95 94 56 53 16 311
Norio Shiraki Japan 10 106 0.6× 55 0.6× 108 1.1× 96 1.7× 52 1.0× 18 340
J Stefoski Mikeljevic United Kingdom 8 252 1.5× 155 1.6× 64 0.7× 44 0.8× 30 0.6× 10 457
D. Dodwell United Kingdom 10 249 1.5× 63 0.7× 105 1.1× 25 0.4× 31 0.6× 14 393
Eyad Abu‐Isa United States 11 126 0.8× 48 0.5× 204 2.2× 70 1.3× 38 0.7× 24 404
Yaw Sinn Chin Australia 12 78 0.5× 115 1.2× 180 1.9× 89 1.6× 24 0.5× 26 414
I. Kunkler United Kingdom 7 112 0.7× 91 1.0× 41 0.4× 28 0.5× 71 1.3× 22 301
Ashray Gunjur Australia 10 116 0.7× 51 0.5× 84 0.9× 52 0.9× 14 0.3× 30 341
X. Sanz Spain 11 136 0.8× 168 1.8× 147 1.6× 135 2.4× 20 0.4× 32 455
Lagrange Jl France 10 128 0.8× 30 0.3× 144 1.5× 68 1.2× 10 0.2× 32 340
Edward D. Green United States 9 116 0.7× 146 1.5× 95 1.0× 173 3.1× 54 1.0× 12 435

Countries citing papers authored by J Dewar

Since Specialization
Citations

This map shows the geographic impact of J Dewar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Dewar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Dewar more than expected).

Fields of papers citing papers by J Dewar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Dewar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Dewar. The network helps show where J Dewar may publish in the future.

Co-authorship network of co-authors of J Dewar

This figure shows the co-authorship network connecting the top 25 collaborators of J Dewar. A scholar is included among the top collaborators of J Dewar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Dewar. J Dewar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Robertson, J.F.R., Antonio Llombart‐Cussac, Janusz Rolski, et al.. (2010). Abstract S1-3: A Comparison of Fulvestrant 500 mg with Anastrozole as First-Line Treatment for Advanced Breast Cancer: Follow-Up Analysis from the ‘FIRST’ Study. Cancer Research. 70(24_Supplement). S1–3. 26 indexed citations
2.
Reis, Márcia Martins, M. Tavakoli, J Dewar, et al.. (2009). Evaluation of a surveillance programme for women with a family history of breast cancer. Journal of Medical Genetics. 46(5). 319–323. 3 indexed citations
3.
Brown, J. E., Eugène McCloskey, J Dewar, et al.. (2007). The Use of Bone Markers in a 6-Week Study to Assess the Efficacy of Oral Clodronate in Patients with Metastatic Bone Disease. Calcified Tissue International. 81(5). 341–351. 20 indexed citations
4.
Dodwell, David, Karen Clements, Gavin P. Lawrence, et al.. (2007). Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane Project. British Journal of Cancer. 97(6). 725–729. 29 indexed citations
5.
Owen, John R., Joanne Haviland, Judith M. Bliss, et al.. (2007). 2026 ORAL Results of the UK standardisation of breast radiotherapy (START) trials testing hypofractionation for early breast cancer – on behalf of the START trials centres. European Journal of Cancer Supplements. 5(4). 191–192. 1 indexed citations
6.
Brown, Janet E., Eugène McCloskey, J Dewar, et al.. (2004). A double blind, parallel, placebo controlled, dose ranging study on efficacy and safety of oral clodronate in cancer induced osteolysis measured by biochemical markers of bone resorption. Journal of Clinical Oncology. 22(14_suppl). 8056–8056. 1 indexed citations
7.
Brown, J. E., Eugene McCloskey, J Dewar, et al.. (2004). A double blind, parallel, placebo controlled, dose ranging study on efficacy and safety of oral clodronate in cancer induced osteolysis measured by biochemical markers of bone resorption. Journal of Clinical Oncology. 22(14_suppl). 8056–8056. 2 indexed citations
8.
Dewar, J, Jean‐Marc Nabholtz, J. Bonneterre, et al.. (2001). The effect of anastrozole (Arimidex™) on serum lipids — a randomized comparison of Anastrozole (AN) vs Tamoxifen (TAM) in Postmenopausal women with Advanced Breast Cancer. European Journal of Cancer. 37. 5–5. 20 indexed citations
9.
Dewar, J, et al.. (1999). Breast Cancer in Scotland: Changes in Treatment and Work-Load. Clinical Oncology. 11(1). 52–54. 2 indexed citations
10.
Bishop, James F., J Dewar, Guy C. Toner, et al.. (1997). A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand.. PubMed. 24(5 Suppl 17). S17–5. 9 indexed citations
11.
Arriagada, R., Hugues de Thé, Thierry Le Chevalier, et al.. (1990). Limited small cell lung cancer: Possible prognostic impact of initial chemotherapy doses. Lung Cancer. 6(1-2). 58–58. 17 indexed citations
12.
Arriagada, R., H Mouriesse, C. Hanzen, et al.. (1989). Limited small cell lung cancer treated by combined radiotherapy and chemotherapy: evaluation of a grading system of lung fibrosis. Radiotherapy and Oncology. 14(1). 1–8. 30 indexed citations
13.
Dewar, J & G.R. Kerr. (1985). Value of routine follow up of women treated for early carcinoma of the breast.. BMJ. 291(6507). 1464–1467. 78 indexed citations
14.
Dewar, J & W. Duncan. (1985). A retrospective study of the role of radiotherapy in the treatment of soft-tissue sarcoma. Clinical Radiology. 36(6). 629–632. 27 indexed citations
15.
Cosset, Jean‐Marc, et al.. (1985). Interstitial thermoradiotherapy: A technical and clinical study of 29 implantations performed at the Institut Gustave-Roussy. International Journal of Hyperthermia. 1(1). 3–13. 44 indexed citations
16.
Lane, Rodney J. & J Dewar. (1978). Bilateral aneuralgic amyotrophy.. BMJ. 1(6117). 895.1–895. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026